• Aucun résultat trouvé

[PDF] Top 20 B cell differentiation is defective in Multiple Sclerosis patients

Has 10000 "B cell differentiation is defective in Multiple Sclerosis patients" found on our website. Below are the top 20 most common "B cell differentiation is defective in Multiple Sclerosis patients".

B cell differentiation is defective in Multiple Sclerosis patients

B cell differentiation is defective in Multiple Sclerosis patients

... of B-cell depleting therapies in relapsing multiple sclerosis (MS) have suggested that B cells may contribute to MS pathogenesis, potentially through antibody independent ... Voir le document complet

2

CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is involved in T cell adhesion

CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is involved in T cell adhesion

... + cell binding to fibronectin (Fig. 3c). CYFIP2 is a member of a larger tetrameric complex that regulates WAVE1 protein [10], but its role in this complex remains ...role in facilitating T ... Voir le document complet

12

The IL‐27/IL‐27R axis is altered in CD4 + and CD8 + T lymphocytes from multiple sclerosis patients

The IL‐27/IL‐27R axis is altered in CD4 + and CD8 + T lymphocytes from multiple sclerosis patients

... IL-12 is reduced in MS patients Pro-inflammatory Th1/Tc1 and Th17/Tc17 subsets contribute to the pathobiology of MS and ...polarisation in animal models of MS has been ...involved in ... Voir le document complet

19

Vitamin D/CD46 Crosstalk in Human T Cells in Multiple Sclerosis

Vitamin D/CD46 Crosstalk in Human T Cells in Multiple Sclerosis

... observed in our in vitro activation conditions. This is suggestive of the activation of the CD46 pathway by vitamin D in vivo in these ...CD226 in the control of the immune ... Voir le document complet

17

Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis

Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis

... anti-MOG B cells. In vitro analyses were unable to detect discrete changes in surface molecules involved in B cell homing in noncirculating sites of the immune ...It ... Voir le document complet

13

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.

... a defective BBB being a common finding that precedes clinical or pathological signs of MS ...shown in vitro that mast cell activation can lead to neuronal damage by indu- cing astroglia to produce ... Voir le document complet

10

Primary high-grade B-cell central nervous system lymphoma in a patient with tumefactive multiple sclerosis treated with Natalizumab.

Primary high-grade B-cell central nervous system lymphoma in a patient with tumefactive multiple sclerosis treated with Natalizumab.

... (PCNSL) is a rare high-grade non-Hodgkin’s lymphoma. In immunocompetent patients, they are almost exclusively of B-cell type with an incidence of 0,3/100 000 between 35 and 44 years of ... Voir le document complet

1

Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation

Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation

... semantics in a group of non-clinically depressed RRMS patients with mild-to-moderate disease ...functioning in MS, is that MS patients, regardless of their scores on different cognitive ... Voir le document complet

13

A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.

A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.

... progressive patients with active disease Although initially separate criteria were proposed for patients with primary and secondary progressive disease the working party decided that the 2013 revisions ... Voir le document complet

8

Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients

Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients

... aHSCT in seven SSc patients [8]. Recovery of CD3+ T cell reconstitution was delayed with persistent CD4+ T cell ...circulating B cell levels were inversely associated with ... Voir le document complet

10

Mass Cytometry Identifies Expansion of T-bet(+) B Cells and CD206(+) Monocytes in Early Multiple Sclerosis

Mass Cytometry Identifies Expansion of T-bet(+) B Cells and CD206(+) Monocytes in Early Multiple Sclerosis

... roles in the pathogenesis as antigen-presenting cells (in periphery and inside the CNS) but also as effector cells (inside the CNS) ( 6 ...MS patients, and data are not consistent ( 27 , 28 ... Voir le document complet

13

Systemic Dysfunction of Osteoblast Differentiation in Adipose-Derived Stem Cells from Patients with Multiple Myeloma

Systemic Dysfunction of Osteoblast Differentiation in Adipose-Derived Stem Cells from Patients with Multiple Myeloma

... of patients is relatively small and larger series are needed to confirm our ...AT is a heterogeneous tissue composed of two cell fractions, the adipocyte and the stroma-vascular fraction ... Voir le document complet

17

A Belgian consensus protocol for autologous haematopoietic stem cell transplantation in multiple sclerosis

A Belgian consensus protocol for autologous haematopoietic stem cell transplantation in multiple sclerosis

... for patients and referring ...stated in the consensus protocol should not need compulsory external ...When in doubt or when deviation of standard criteria is deemed to be justified this should ... Voir le document complet

8

Activation-induced cell death in T lymphocytes from multiple sclerosis patients.

Activation-induced cell death in T lymphocytes from multiple sclerosis patients.

... AICD is decreased in T cells from RRMS patients To evaluate AICD in T cells, PBMC were cultured in the presence or absence of PHA and annexin V was used as a marker of ...apoptosis. ... Voir le document complet

5

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients

... that patients suffering from RRMS exhibit increased IL-27 expression solely in the CNS compartment as its levels were increased in RRMS patients compared to controls in CSF but not ... Voir le document complet

8

Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis

Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis

... OPC differentiation and myelination [ 34 ...development in the mouse spinal ...terminal differentiation [ 36 ...their differentiation [ 37 , 38 ...implicated in oligodendrocyte lineage ... Voir le document complet

16

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis

... it is well established that SSc patients show several B-cell abnormalities, such as an overexpression of CD19 as well as a disturbed peripheral homeostasis ...SSc patients also show an ... Voir le document complet

10

[Therapeutic management of cognitive disorders in multiple sclerosis]

[Therapeutic management of cognitive disorders in multiple sclerosis]

... les patients atteints de SEP a montré que la simple répétition ne suffisait pas à optimiser les performances mnésiques et que la solution était sans doute dans le réapprentissage de stratégies ...de ... Voir le document complet

23

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France

... MS is not homogenous in the world ...north in Japan [2] and Europe [3], and from north to south in Australia [4] and South America ...variations in many geographical areas, the ... Voir le document complet

15

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

... increases cell proliferation. One hypothesis could be that deregulation of Bcl‑B in plasmocytes might represent an important pri‑ mary prosurvival event necessary for the initiation of MM ... Voir le document complet

19

Show all 10000 documents...